Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Clinical Genomics Laboratory
Explore this Website
Home
About Us
Toggle About Us menu options
Faculty Directory
News & Updates
Publications
Testing Portfolio
Toggle Testing Portfolio menu options
My Heme Panel
Oncomine
Oncomine Comprehensive Assay v2
TruSight Oncology 500 Assay
Ordering a Test
Toggle Ordering a Test menu options
For WCM/NYP Physicians
For External Physicians
Financial Services
Your Privacy
Contact Us
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Testing Portfolio
Ordering a Test
Financial Services
Your Privacy
Contact Us
Home
Publications
Publications
Faculty Directory
News & Updates
Publications
Publications
Found 19 results
Author
Title
Type
[
Year
]
Filters:
First Letter Of Last Name
is
R
[Clear All Filters]
2019
Fernandez EM, Eng K, Beg S, Beltran H, Faltas BM, Mosquera JMiguel, Nanus DM, Pisapia DJ, Rao RA, Robinson BD et al.
. 2019.
Cancer-Specific Thresholds Adjust for Whole Exome Sequencing-based Tumor Mutational Burden Distribution.
.
JCO Precis Oncol. 3
Fernandez EM, Eng K, Beg S, Beltran H, Faltas BM, Mosquera JMiguel, Nanus DM, Pisapia DJ, Rao RA, Robinson BD et al.
. 2019.
Cancer-Specific Thresholds Adjust for Whole Exome Sequencing-based Tumor Mutational Burden Distribution.
.
JCO Precis Oncol. 3
Fernandez EM, Eng K, Beg S, Beltran H, Faltas BM, Mosquera JMiguel, Nanus DM, Pisapia DJ, Rao RA, Robinson BD et al.
. 2019.
Cancer-Specific Thresholds Adjust for Whole Exome Sequencing-based Tumor Mutational Burden Distribution.
.
JCO Precis Oncol. 3
Ma J, Redmond D, Miyaguchi A, Nam AS, Nie K, Mathew S, Elemento O, Tam W
. 2019.
Exploring tumor clonal evolution in bone marrow of patients with diffuse large B-cell lymphoma by deep IGH sequencing and its potential relevance in relapse.
.
Blood Cancer J. 9(9):69.
Sailer V, Eng KWa, Zhang T, Bareja R, Pisapia DJ, Sigaras A, Bhinder B, Romanel A, Wilkes D, Sticca E et al.
. 2019.
Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer.
.
JCO Precis Oncol. 3
Sailer V, Eng KWa, Zhang T, Bareja R, Pisapia DJ, Sigaras A, Bhinder B, Romanel A, Wilkes D, Sticca E et al.
. 2019.
Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer.
.
JCO Precis Oncol. 3
Sailer V, Eng KWa, Zhang T, Bareja R, Pisapia DJ, Sigaras A, Bhinder B, Romanel A, Wilkes D, Sticca E et al.
. 2019.
Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer.
.
JCO Precis Oncol. 3
Sailer V, Eng KWa, Zhang T, Bareja R, Pisapia DJ, Sigaras A, Bhinder B, Romanel A, Wilkes D, Sticca E et al.
. 2019.
Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer.
.
JCO Precis Oncol. 3
Sailer V, Eng KWa, Zhang T, Bareja R, Pisapia DJ, Sigaras A, Bhinder B, Romanel A, Wilkes D, Sticca E et al.
. 2019.
Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer.
.
JCO Precis Oncol. 3
Sailer V, Eng KWa, Zhang T, Bareja R, Pisapia DJ, Sigaras A, Bhinder B, Romanel A, Wilkes D, Sticca E et al.
. 2019.
Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer.
.
JCO Precis Oncol. 3
Nam AS, Kim K-T, Chaligne R, Izzo F, Ang C, Taylor J, Myers RM, Abu-Zeinah G, Brand R, Omans ND et al.
. 2019.
Somatic mutations and cell identity linked by Genotyping of Transcriptomes.
.
Nature. 571(7765):355-360.
2018
Rosenbaum JN, Bloom R, Forys JT, Hiken J, Armstrong JR, Branson J, McNulty S, Velu PD, Pepin K, Abel H et al.
. 2018.
Genomic heterogeneity of ALK fusion breakpoints in non-small-cell lung cancer.
.
Mod Pathol. 31(5):791-808.
2017
Huang L, Fernandes H, Zia H, Tavassoli P, Rennert H, Pisapia D, Imielinski M, Sboner A, Rubin MA, Kluk M et al.
. 2017.
The cancer precision medicine knowledge base for structured clinical-grade mutations and interpretations.
.
J Am Med Inform Assoc. 24(3):513-519.
Huang L, Fernandes H, Zia H, Tavassoli P, Rennert H, Pisapia D, Imielinski M, Sboner A, Rubin MA, Kluk M et al.
. 2017.
The cancer precision medicine knowledge base for structured clinical-grade mutations and interpretations.
.
J Am Med Inform Assoc. 24(3):513-519.
2016
Rennert H, Eng K, Zhang T, Tan A, Xiang J, Romanel A, Kim R, Tam W, Liu Y-C, Bhinder B et al.
. 2016.
Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care.
.
NPJ Genom Med. 1
Rennert H, Eng K, Zhang T, Tan A, Xiang J, Romanel A, Kim R, Tam W, Liu Y-C, Bhinder B et al.
. 2016.
Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care.
.
NPJ Genom Med. 1
Rennert H, Eng K, Zhang T, Tan A, Xiang J, Romanel A, Kim R, Tam W, Liu Y-C, Bhinder B et al.
. 2016.
Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care.
.
NPJ Genom Med. 1
Rennert H, Eng K, Zhang T, Tan A, Xiang J, Romanel A, Kim R, Tam W, Liu Y-C, Bhinder B et al.
. 2016.
Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care.
.
NPJ Genom Med. 1
2015
Cheng DT, Mitchell TN, Zehir A, Shah RH, Benayed R, Syed A, Chandramohan R, Liu ZYu, Won HH, Scott SN et al.
. 2015.
Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology.
.
J Mol Diagn. 17(3):251-64.